The ImmunoVerse™
The ImmunoVerse™
Podcast Description
The ImmunoVerse™ is a monthly podcast exploring the past, present and future of immunotherapy and delving into every intricacy of the body's immune system. Hosted by Moffitt Cancer Center President and CEO, Dr. Patrick Hwu, each episode highlights the trailblazing visionaries who are pushing boundaries in this ever-evolving, world-changing field.
Podcast Insights
Content Themes
The podcast explores the intricacies of the immune system and immunotherapy, with episodes delving into historical milestones like the Origins of Cancer Immunotherapy featuring Dr. Steven Rosenberg, alongside discussions about current advances in cancer treatment and predictions for future innovations in the field.
The ImmunoVerse™ is a monthly podcast exploring the past, present and future of immunotherapy and delving into every intricacy of the body’s immune system. Hosted by Moffitt Cancer Center President and CEO, Dr. Patrick Hwu, each episode highlights the trailblazing visionaries who are pushing boundaries in this ever-evolving, world-changing field.
Dr. Patrick Hwu sits down with Dr. Ira Mellman, president of research at the Parker Institute for Cancer Immunotherapy, to explore the science behind immune activation and its application to cancer treatment.
Together, they discuss Dr. Mellman’s pioneering work on dendritic cells and endosomes, the cancer-immunity cycle, and why checkpoint inhibitors only work when enough tumor-fighting T cells are already present. Dr. Mellman explains how personalized cancer vaccines could generate stronger immune responses, the challenges of making these treatments scalable, and why ambitious science and thoughtful mentorship are essential to advancing immunotherapy.
What You’ll Learn From Dr. Ira Mellman
- How endosomes and dendritic cells shape antigen presentation and T-cell activation
- The role of the cancer-immunity cycle in understanding immune responses and treatment resistance
- Why rate-limiting steps in the cancer-immunity cycle matter for immunotherapy
- How cancer vaccines can generate antigen-specific T-cell responses
- The importance of innate immune signals in developing effective cancer vaccines
- Emerging approaches to personalized cancer vaccines and their scalability
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.